Biotech Investment Analyst - Specialist

About the job

Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark , General Catalyst , Peter Thiel , Adam D'Angelo , Larry Summers , and Jack Dorsey .

Position: Biotech Investment Analyst — Drug Asset & Company Assessment
Type: Contract
Compensation: $120–$200/hour
Location: Remote
Duration: 1–2 week pilot
Commitment: 10–20 hours
Role Responsibilities

- Create and critique rubrics that analyze commercial drugs and drug-development programs.

- Provide overall company and asset assessment, including mechanism, clinical data, competitive position, and value drivers.

- Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions.

- Apply your assessment across the pilot's set of companies, approximately 5–10.

- Work independently and asynchronously to meet deadlines and improve AI model performance .

Qualifications

Must-Have

- US-based biotech/healthcare investment analyst with a specialist-fund background.

- Familiarity with biotech/pharma development programs.

- Able to assess a drug asset and the company behind it end-to-end.

- 5+ years evaluating biotech/pharma companies or assets.

Compensation & Legal
- Hourly contractor

Application Process (Takes 20–30 mins to complete)

- Upload resume

- AI interview based on your resume

- Submit form

Resources & Support

- For details about the interview process and platform information, please check:

- For any help or support, reach out to:

PS: Our team reviews applications daily. Please complete your AI interview and application steps to be considered for this opportunity.

Originally posted on Himalayas